Biolase, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink

7 Nov 2024

BIOLQ

10-Q: BIOLASE, Inc. Reports Q3 2024 Results Amid Bankruptcy Proceedings and Asset Sale

BIOLASE, Inc. announces its Q3 2024 financial results while navigating Chapter 11 bankruptcy and an ongoing asset sale process.

OTC.Pink

8 Aug 2024

BIOLQ

Biolase, INC

10-Q: BIOLASE Reports Q2 2024 Results Amidst Financial Challenges and Nasdaq Delisting

BIOLASE's Q2 2024 results reveal a decrease in revenue and a net loss, alongside ongoing concerns about the company's ability to continue as a going concern and its recent delisting from the Nasdaq.

OTC.Pink

13 May 2024

BIOLQ

Biolase, INC

10-Q: BIOLASE Reports Q1 2024 Results: Revenue Declines Slightly Amidst Ongoing Nasdaq Compliance Concerns

BIOLASE, Inc. reports a slight decrease in revenue for Q1 2024, alongside a net loss and continued efforts to maintain Nasdaq compliance.